Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nicolette Chun"'
Publikováno v:
Cancer Genetics. :22-27
Recent changes in oncology practice guidelines indicate that mutations in cancer susceptibility genes identified on tumor genomic profiling (TGP) should prompt confirmatory germline testing. Our study aimed to determine the proportion of patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6787efcd2b8a15051b593cb385ab3bc4
https://doi.org/10.1016/j.cancergen.2022.09.001
https://doi.org/10.1016/j.cancergen.2022.09.001
Publikováno v:
Cancer Genetics. :16-22
Clinicians involved in cancer treatment often utilize somatic tumor sequencing to help tailor chemotherapy and immunotherapy. However, somatic tumor sequencing can also identify patients at risk for germline pathogenic variants causing cancer predisp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecf33f3a665b25bf93822d6d3997be0b
https://doi.org/10.1016/j.cancergen.2022.02.010
https://doi.org/10.1016/j.cancergen.2022.02.010
Autor:
Katherine, Vlessis, Natasha, Purington, Nicolette, Chun, Sigurdis, Haraldsdottir, James M, Ford
Publikováno v:
JNCI Cancer Spectrum
Background The National Comprehensive Cancer Network (NCCN) recommends germline testing for pathogenic BRCA1/2 mutations identified by somatic tumor sequencing. The aim of this study was to explore whether patients at Stanford with somatic BRCA1/2 mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f7f583d316ffeb37caeaf1f74b784dd8
https://pubmed.ncbi.nlm.nih.gov/32259017
https://pubmed.ncbi.nlm.nih.gov/32259017